Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences (TSE:DRUG)
:DRUG
Bright Minds Biosciences (DRUG) Ownership Overview
11.33% Insiders
1.17%
Mutual Funds
36.97% Other Institutional Investors
2.82% ETFs
47.71% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (TSE:DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 40.95% of the company’s stock is owned by Institutional Investors, 11.33% is owned by Insiders, and 47.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 07, 2025 | xxxxxxxxxxxxx | C$120960 | |
Mar 07, 2025 | xxxxxxxxxxxxx | $180985 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,004,900 | Insider | 10.33% | 87,976,985 | |
| 449,290 | Institution | 4.62% | 39,334,441 | |
| 206,427 | Institution | 2.12% | 18,072,271 | |
| 183,645 | Institution | 1.89% | 16,077,752 | |
| 57,600 | Insider | 0.59% | 5,042,765 | |
| 54,759 | Institution | 0.56% | 4,794,041 | |
| 49,421 | Institution | 0.51% | 4,326,710 | |
| 28,308 | Institution | 0.29% | 2,478,309 | |
| 25,960 | Institution | 0.27% | 2,272,746 | |
| 20,609 | Insider | 0.21% | 1,804,277 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 49,421 | Institution | 0.51% | 4,326,710 | |
| 25,960 | Institution | 0.27% | 2,272,746 | |
| 11,604 | Institution | 0.12% | 1,015,907 | |
| 6,391 | Institution | 0.07% | 559,519 | |
| 5,987 | Institution | 0.06% | 524,150 | |
| 4,990 | Institution | 0.05% | 436,865 | |
| 2,246 | Institution | 0.02% | 196,633 | |
| 1,504 | Institution | 0.02% | 131,672 | |
| 1,500 | Institution | 0.02% | 131,322 | |
| 900 | Institution | <0.01% | 78,793 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 124,291 | Institution | 1.28% | 10,813,317 | |
| 42,952 | Institution | 0.44% | 3,736,824 | |
| 12,964 | Institution | 0.13% | 1,127,868 | |
| 11,813 | Institution | 0.12% | 1,027,731 | |
| 7,300 | Institution | 0.08% | 628,092 | |
| 2,233 | Institution | 0.02% | 201,841 | |
| 2,033 | Institution | 0.02% | 176,871 | |
| 1,724 | Institution | 0.02% | 149,988 | |
| 529 | Institution | <0.01% | 45,511 | |
| 192 | Institution | <0.01% | 17,355 |
FAQ
Who Owns Bright Minds Biosciences (TSE:DRUG)?
According to the latest TipRanks data, approximately 36.97% of the company's stock is held by institutional investors, 11.33% is held by insiders, and 47.71% is held by retail investors.
What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.97% of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors.
What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.71% of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors.
Who owns the most shares of Bright Minds Biosciences (TSE:DRUG)?
Ian Mcdonald owns the most shares of Bright Minds Biosciences (TSE:DRUG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.